Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma-Reference-Cited by-同舟云学术

Elranatamab efficacy in MagnetisMM-3 compared with real-world control arms in triple-class refractory multiple myeloma

Published:2024-02-28 Issue:17 Volume:20 Page:1175-1189
ISSN:1479-6694
Container-title:Future Oncology
language:en
Short-container-title:Future Oncology

Author:

Costa Luciano J¹^ORCID,LeBlanc Thomas W²^ORCID,Tesch Hans³^ORCID,Sonneveld Pieter⁴^ORCID,Kyle Ryan P⁵^ORCID,Sinyavskaya Liliya⁵^ORCID,Hlavacek Patrick⁶^ORCID,Meche Aster⁶^ORCID,Ren Jinma⁷^ORCID,Schepart Alex⁶^ORCID,Aydin Didem⁶,Nador Guido⁸,DiBonaventura Marco daCosta⁶^ORCID

Affiliation:

1. The University of Alabama at Birmingham, School of Medicine - Medicine - Hematology & Oncology, Birmingham, AL 35294, USA

2. Division of Hematologic Malignancies & Cellular Therapy, Duke University School of Medicine, Durham, NC 27705-3976, USA

3. Bethanien Hospital, Center for Hematology and Oncology, Frankfurt, 60389, Germany

4. Department of Hematology, Erasmus University, 3062, PA Rotterdam, The Netherlands

5. Statlog, Montréal, Québec, H3B 2E3, Canada

6. Pfizer Inc, New York, NY 10001, USA

7. Pfizer Inc, Collegeville, PA 19426, USA

8. Pfizer Inc, Tadworth, Surrey, KT20 7NS, UK

Funder

Pfizer

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.2217/fon-2023-0995

Reference29 articles.

1. Multiple Myeloma: Diagnosis and Treatment

2. The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study

3. Symptom Burden, Perceived Control, and Quality of Life Among Patients Living With Multiple Myeloma

4. How I treat triple‐class refractory multiple myeloma

5. Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bispecific Antibodies for Multiple Myeloma: Recent Advancements and Strategies for Increasing Their Efficacy;Frontiers in Bioscience-Landmark;2024-06-17